Walking Fish Therapeutics rallies $73m Series A

Walking Fish Therapeutics, a provider of B cell therapeutics, has secured $73 million in Series A funding.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this